New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD exacerbation with a dry powder inhaler vs. a metered-dose or soft mist ...

New FDA-approved medical treatments can be transformative for patients and families, often providing them with more years to live and an enhanced quality of life. 1 Delivering timely, high-quality ...

REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx Corporation is announcing that over 20,000 patients have been treated worldwide with their Zephyr® ...

Please provide your email address to receive an email when new articles are posted on . A variety of options/tools are needed when treating patients with severe emphysema and breathlessness. A phase 3 ...

Patients with severe pulmonary hypertension (PH) and chronic obstructive pulmonary disease (COPD) can now be identified using three widely available clinical variables, all of which can be measured ...

COLLEGEVILLE, Pa. (WPVI) -- It's been five years since the FDA approved the first valves to treat severe emphysema. And since then, they've turned life around for patients, including a Montgomery ...

David Lynch passed away at the age of 78—less than six months after announcing he had emphysema—a chronic and distressing ...

NORTH PHILADELPHIA (WPVI) -- There's a potential new treatment for severe emphysema, and Philadelphia is a key test site for this small device with big potential to improve lives. In COPD (Chronic ...

While there is currently no cure for emphysema, various medications can help manage it. These may include bronchodilators, steroids, and antibiotics. They aim to manage symptoms, improve quality of ...

Patients with both chronic obstructive pulmonary disease (COPD) and severe pain are at an almost 40% predicted probability of falling, indicating the potential interaction between the conditions.